Hca Healthcare, INC

HCA Healthcare, Inc. announced an increase in its subsidiary's commercial paper program from $4 billion to $8 billion.

HCA Healthcare announced its second quarter 2026 financial and operating results, reporting increased revenues and net income, alongside a quarterly cash dividend declaration.

HCA Healthcare announced preliminary Q2 2026 results, anticipating revenue of $20.230 billion and net income of $1.699 billion, while revising its full-year 2026 guidance.

HCA Healthcare announced that Dr. Michael Cuffe will step down as Executive Vice President and Chief Clinical Officer effective August 31, 2026, moving to a transitional role until February 2027.

HCA Healthcare's Annual Meeting saw the election of nine directors, ratification of Ernst & Young LLP as auditors, and approval of executive compensation, while two shareholder proposals were not approved.

HCA Healthcare plans a new senior notes offering to fund the redemption of $2.5 billion in existing debt due in 2026.

HCA Healthcare, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting increased revenues and net income, alongside strategic updates on acquisitions and debt management.

HCA Healthcare reported a strong third quarter with significant increases in revenue and diluted EPS, driven by higher patient volumes and effective labor management, despite rising interest expenses and policy uncertainties.

HCA Healthcare reports strong second-quarter 2025 financial results with significant revenue and earnings growth, alongside strategic debt refinancing and share repurchases, while navigating new healthcare policy challenges.

HCA Healthcare's first quarter 2025 shows revenue growth of 5.7% driven by increased admissions and revenue per admission, alongside strategic debt refinancing activities.

HCA Healthcare's third-quarter 2024 earnings show a significant increase in revenue and net income compared to the same period last year, despite challenges from Hurricane Helene.

HCA Healthcare's second quarter 2024 results show a significant increase in revenue and net income, driven by higher admissions and revenue per equivalent admission.

HCA Healthcare reports robust financial performance in 2025 with significant revenue and net income growth, driven by increased patient volumes and strategic investments in digital and AI capabilities.

HCA Healthcare's 2024 annual report reveals increased revenues and net income, fueled by a rise in admissions and equivalent admissions.

HCA Healthcare's recent 10-K filing details updates to its U.S. Guarantee Agreement and provides a comprehensive overview of its business, financial performance, and risk factors.

HCA Healthcare EVP and CFO Mike Marks transferred 3,336 shares of common stock to a family trust.

Director William R. Frist acquired 809 restricted share units as part of his annual director compensation package.

Director Thomas F. Frist III acquired 1,041 restricted share units as part of his annual director compensation package.

Director Andrea B. Smith was granted 509 restricted share units as part of HCA Healthcare's annual director equity compensation.

Director Wayne Joseph Riley acquired 509 restricted share units as part of an annual director equity award.

Director Michael W. Michelson received an equity grant of 925 restricted share units as part of his annual compensation.

HCA Healthcare's definitive proxy statement details proposals for its upcoming 2026 annual meeting, including director elections, auditor ratification, executive compensation, and two stockholder initiatives.

HCA Healthcare's upcoming annual meeting on April 24, 2025, will address director elections, executive compensation, and amendments to the stock incentive plan and corporate charter, among other proposals.

HCA Healthcare will hold its annual meeting of stockholders on April 24, 2025, in a virtual format, to vote on director elections, executive compensation, and several stockholder proposals.

HCA Healthcare, Inc. is holding its annual meeting on April 25, 2024, and has provided details on how stockholders can vote on key proposals.

HCA Healthcare's proxy statement details proposals for the upcoming annual stockholders meeting, including director elections, auditor ratification, and executive compensation advisory votes.

The Frist family, co-founders of HCA Healthcare, Inc., have reorganized their significant ownership stake through partnership conversions and an exchange of shares, solidifying long-term governance.

Vanguard Capital Management has disclosed a beneficial ownership of 5.25% in HCA Healthcare Inc. common stock as of March 31, 2026.

The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in HCA Healthcare Inc. following an internal corporate realignment.

BlackRock, Inc. has filed an Amendment No. 3 to Schedule 13G, reporting a 4.9% beneficial ownership stake in HCA Healthcare, Inc. as of March 31, 2025.